SCHEMBL5369951

SCHEMBL5369951

Cc1cc(NS(=O)(=O)c2ccc(C)c(C(=O)O)c2)ccc1OCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
MRGPRX4 Q96LA9 4/20 0.50
AR P10275 1/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
WDR5 P61964 3/20 0.47
PKM P14618 1/20 0.46
PPARD Q03181 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
HSD17B2 P37059 1/20 0.44
PPARA Q07869 2/20 0.44
FABP4 P15090 1/20 0.44
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376847 0.89 AR (0.66) POLBARMEN1KMT2AALOX15
SCHEMBL5368419 0.82 POLB (0.66) POLBMEN1KMT2AALOX15MAPK1
SCHEMBL5380353 0.81 AR (0.50) POLBARMEN1KMT2APKM
SCHEMBL5373250 0.81 POLB (0.63) POLBMEN1KMT2AALOX15MAPK1
SCHEMBL5372119 0.79 POLB (0.62) POLBARMEN1KMT2APKM
SCHEMBL4904049 0.79 POLB (0.53) POLBMEN1KMT2AALOX15MAPK1
SCHEMBL5371856 0.79 POLB (0.53) POLBMEN1KMT2AALOX15MAPK1
SCHEMBL4905297 0.77 ADAMTS4 (0.50) POLBARMEN1KMT2AMAPK1
SCHEMBL5342566 0.77 POLB (0.47) POLBMEN1KMT2AALOX15MAPK1
SCHEMBL5369923 0.77 AR (0.66) POLBMRGPRX4ARMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885MRGPRX4 4195/4885AR 885/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885MRGPRX4 4173/4885AR 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.